# Optimal Doses for Drug Provocation Tests to Beta-lactams

> **NCT02839551** · NA · COMPLETED · sponsor: **University Hospital, Montpellier** · enrollment: 1252 (actual)

## Conditions studied

- Drug Hypersensitivity

## Interventions

- **PROCEDURE:** simplified drug provocation test

## Key facts

- **NCT ID:** NCT02839551
- **Lead sponsor:** University Hospital, Montpellier
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-05-04
- **Primary completion:** 2021-11-16
- **Final completion:** 2021-11-16
- **Target enrollment:** 1252 (ACTUAL)
- **Last updated:** 2025-09-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02839551

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02839551, "Optimal Doses for Drug Provocation Tests to Beta-lactams". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02839551. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*